샘플 요청 목록

 카트 문의
시장보고서
상품코드
1744894

세계의 갑상선암 진단 시장

Thyroid Cancer Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 374 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 갑상선암 진단 시장은 2030년까지 67억 달러에 이를 전망

2024년에 53억 달러로 추정되는 갑상선암 진단 세계 시장은 2024-2030년간 CAGR 3.7%로 성장하여 2030년에는 67억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 기구는 CAGR 3.0%를 나타내고, 분석 기간 종료시에는 40억 달러에 이를 것으로 예측됩니다. 소모품 및 액세서리 분야의 성장률은 분석 기간중 CAGR 4.9%로 추정됩니다.

미국 시장은 15억 달러, 중국은 CAGR 6.8%로 성장 예측

미국의 갑상선암 진단 시장은 2024년에 15억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 13억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.8%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.5%와 2.8%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%를 보일 전망입니다.

세계의 '갑상선암 진단' 시장 - 주요 동향과 촉진요인 정리

정밀 종양학 시대, 갑상선암 진단은 어떻게 진화하고 있을까?

분자생물학, 영상기술, 맞춤의료의 발전에 힘입어 갑상선암 진단을 둘러싼 환경이 크게 변화하고 있습니다. 역사적으로 촉진, 초음파, 세침흡인(FNA)에 의존해왔던 갑상선암의 진단은 이제 유전체 프로파일링, 바이오마커 분석, 고해상도 영상진단에 의해 점점 더 많이 지원되고 있습니다. 이러한 도구들은 진단 정확도를 높이고 불필요한 수술을 줄이며 갑상선 유두암, 여포암과 같은 악성 종양을 조기에 발견할 수 있게 해주며, BRAF, RAS, RET, TERT와 같은 유전자 변이를 식별하기 위한 차세대 염기서열 분석(NGS) 패널의 사용은 특히 세포검사가 불확실한 경우에 임상의에게 큰 도움이 됩니다. 특히 세포진단이 불확실한 경우, 임상의가 결절을 양성 또는 악성으로 구분하는 방식에 혁명을 일으키고 있습니다. 방사성 동위원소 및 AI 기반 초음파 데이터 분석 또한 기존 영상 진단의 예측 가치를 향상시켜 보다 확실한 임상적 의사결정을 내릴 수 있게 합니다. 액체 생검은 아직 시작 단계에 불과하지만 비침습적이고 반복 가능한 질병 진행 및 재발 모니터링의 잠재력을 가지고 있습니다. 이러한 기술 혁신은 진단 정확도를 높일 뿐만 아니라 표적 치료와 개인 맞춤형 치료 계획으로 가는 광범위한 추세를 뒷받침하고 있습니다.

갑상선암 발병률 증가로 전 세계 진단의 우선순위가 바뀔까?

세계적으로 갑상선암의 발병률은 영상진단의 보급과 인식의 향상으로 인해, 특히 의료 시스템이 발달한 지역에서 꾸준히 증가하고 있습니다. 이러한 역학적 추세는 공중보건 시스템과 임상 진료소가 갑상선 결절의 조기 발견과 감별을 우선순위에 두도록 촉구하고 있습니다. 갑상선 결절 증가는 대부분 작고 악성도가 낮은 종양의 발견으로 인한 것이지만, 과잉 진단과 과잉 치료에 대한 우려로 인해 보다 섬세한 진단 프레임워크로의 전환이 가속화되고 있습니다. 새로운 가이드라인은 영상진단, 세포검사, 분자검사를 결합하여 환자 관리를 조정하는 위험도 계층화 진단 접근법을 제안하고 있습니다. 아시아, 특히 한국과 중국에서는 환자 수가 증가함에 따라 전국적인 검진 노력과 진단 인프라에 대한 투자가 증가하고 있습니다. 반면, 아프리카와 라틴아메리카 일부 지역에서는 의료에 대한 인식과 접근성이 향상됨에 따라 진단 도구에 대한 수요는 더디지만 증가하고 있습니다. 이러한 세계 변화는 진단 워크플로우를 재구성하고, 비용 효율적이고 확장 가능하며 저침습적인 기술에 대한 수요를 증가시키고 있습니다.

갑상선암 진단의 새로운 표준이 되고 있는 진단 기술은 무엇인가?

갑상선암의 진단 수단은 영상진단, 세포병리, 분자진단에 걸친 혁신적인 기술에 의해 빠르게 확대되고 있습니다. 고주파 초음파 검사는 여전히 초기 평가의 핵심이지만, 엘라스토그래피, 도플러 유량 분석, 결절 형태와 혈관을 분석하는 머신러닝 알고리즘을 통해 진단 정확도가 크게 향상되고 있습니다. 세포학적 평가의 표준인 세침흡인 생검은 유전자 변이 및 발현 프로파일 패널을 평가하는 분자 검사 플랫폼으로 보완되고 있으며, ThyroSeq, Afirma, RosettaGX와 같은 상용화된 분석법은 불확실한 결절의 악성 위험에 대한 귀중한 통찰력을 제공합니다. SPECT/CT 및 PET/CT 영상은 특히 고위험군 및 전이성 환자에서 병기 결정, 재발 모니터링, 치료 반응성 평가에 중요한 역할을 하고 있으며, AI 기반 병리검사 플랫폼은 세포진단 판독의 일관성을 개선하고, AI 기반 병리검사 플랫폼은 세포진단 판독의 일관성 일관성을 향상시키고, 관찰자 간 편차를 감소시키고 있습니다. 최첨단 기술인 혈액 내 순환 종양 DNA(ctDNA)와 마이크로 RNA 시그니처에 대한 조사는 비침습적 감시의 새로운 영역을 추가할 수 있을 것으로 기대되고 있습니다. 이러한 혁신을 통해 갑상선암 진단은 정확성, 효율성, 개인화로 정의되는 미래로 나아가고 있습니다.

갑상선암 진단 시장의 성장에는 몇 가지 요인이 있습니다.

갑상선암 진단 시장의 견조한 성장은 기술적, 인구통계학적, 의료 정책적 요인에 의해 촉진되고 있습니다. 전 세계적으로 갑상선 결절이 증가하고 있으며, 그 중 상당수는 첨단 진단 기술을 통한 감별이 필요한 경우가 많다는 점이 주요 임상 촉진요인으로 작용하고 있습니다. 초음파 및 CT와 같은 고해상도 영상 진단 기술의 사용이 증가함에 따라 더 많은 우발적 인 갑상선 결절이 발견되고 있으며, 그 중 상당수가 진단을 위해 의뢰되고 있습니다. 일상적인 임상에서 분자진단 및 유전체 프로파일링의 가용성이 확대됨에 따라 불확실한 사례에 대한 보다 정확한 평가가 가능해져 진단의 불확실성이 감소하고 환자 관리 경로가 개선되고 있습니다. 또한, 갑상선 결절 평가에서 위험 기반 개별화 접근법으로 임상 가이드라인이 변화함에 따라 병원과 진단 실험실가 통합 진단 플랫폼에 대한 투자를 촉진하고 있습니다. 비침습적이고 정확한 진단에 대한 환자들의 요구도 액체 생검과 첨단 영상 진단 도구의 채택에 영향을 미치고 있습니다. 인구 고령화, 신흥국의 의료 접근성 향상, 내분비암에 대한 인식이 높아짐에 따라 진단 건수가 더욱 증가하고 있습니다. 또한, 가치 기반 치료 및 결과 최적화 추세는 의료진이 불필요한 시술을 줄이고 진단 정확도를 향상시키는 기술을 채택하도록 유도하여 첨단 갑상선암 진단 시장 모멘텀을 강화시키고 있습니다.

부문

제품 유형(장비, 소모품, 액세서리);검사 유형(영상 검사, 생검, 혈액검사, 기타 검사 유형);최종사용자(병원, 제휴 연구소, 독립 진단 실험실, 영상 진단센터, 암 연구기관, 기타 최종사용자)

조사 대상 기업 예(총 32개사)

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bayer AG
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Canon Inc.
  • Cepheid
  • DiaSorin S.p.A.
  • Eli Lilly and Company
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Hologic Inc.
  • Illumina Inc.
  • Koninklijke Philips N.V.
  • Labcorp
  • Merck KGaA
  • Myriad Genetics Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Siemens Healthineers

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 수익원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월: 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월: 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석 :

미국 <>& 중국 <>& 멕시코 <>& 캐나다 <>&EU <>& 일본 <>& 인도 <>& 기타 176개국

업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.06.19

Global Thyroid Cancer Diagnostics Market to Reach US$6.7 Billion by 2030

The global market for Thyroid Cancer Diagnostics estimated at US$5.3 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Consumables & Accessories segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 6.8% CAGR

The Thyroid Cancer Diagnostics market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global "Thyroid Cancer Diagnostics" Market - Key Trends & Drivers Summarized

How Is Thyroid Cancer Diagnostics Evolving in the Age of Precision Oncology?

The landscape of thyroid cancer diagnostics is undergoing a significant transformation, driven by advancements in molecular biology, imaging technologies, and personalized medicine. Historically reliant on palpation, ultrasound, and fine-needle aspiration (FNA), thyroid cancer detection is now increasingly supported by genomic profiling, biomarker analysis, and high-resolution imaging. These tools are enhancing diagnostic accuracy, reducing unnecessary surgeries, and enabling earlier detection of malignancies such as papillary and follicular thyroid carcinomas. The use of next-generation sequencing (NGS) panels for identifying mutations in genes like BRAF, RAS, RET, and TERT is revolutionizing how clinicians distinguish between benign and malignant nodules, particularly in cases with indeterminate cytology. Radiomics and AI-based interpretation of ultrasound data are also improving the predictive value of traditional imaging, allowing for more confident clinical decision-making. Liquid biopsies, though still emerging, hold potential for non-invasive, repeatable monitoring of disease progression and recurrence. These technological innovations are not only enhancing diagnostic precision but also supporting the broader trend toward targeted therapies and individualized treatment planning.

Are Rising Thyroid Cancer Rates Changing the Global Diagnostic Priorities?

The global incidence of thyroid cancer has been steadily increasing, particularly in regions with advanced healthcare systems, due in part to widespread use of imaging and increased awareness. This epidemiological trend is prompting public health systems and clinical practices to prioritize the early detection and differentiation of thyroid nodules, many of which are asymptomatic and discovered incidentally during unrelated imaging exams. While much of the increase is attributed to the detection of small, indolent tumors, concerns over overdiagnosis and overtreatment are fueling a shift toward more nuanced diagnostic frameworks. Emerging guidelines advocate for risk-stratified diagnostic approaches that combine imaging features, cytology, and molecular testing to tailor patient management. In Asia, particularly South Korea and China, rising case numbers have led to national screening efforts and increased investment in diagnostic infrastructure. Meanwhile, underserved regions in Africa and parts of Latin America are seeing a delayed but growing demand for diagnostic tools as awareness and access to healthcare improve. These global shifts are reshaping diagnostic workflows and intensifying demand for cost-effective, scalable, and minimally invasive technologies.

What Diagnostic Technologies Are Setting New Standards in Thyroid Cancer Detection?

The diagnostic arsenal for thyroid cancer is expanding rapidly, with innovations that span imaging, cytopathology, and molecular diagnostics. High-frequency ultrasonography remains the cornerstone of initial evaluation, but its diagnostic accuracy is now being significantly enhanced by elastography, Doppler flow analysis, and machine learning algorithms that analyze nodule morphology and vascularity. Fine-needle aspiration biopsy, the gold standard for cytological evaluation, is being supplemented with molecular testing platforms that evaluate panels of gene mutations and expression profiles. Commercial assays such as ThyroSeq, Afirma, and RosettaGX offer valuable insights into the malignancy risk of indeterminate nodules, guiding whether surgery is warranted. SPECT/CT and PET/CT imaging are playing a growing role in staging, recurrence monitoring, and therapy response assessment, particularly in high-risk or metastatic cases. AI-assisted pathology platforms are improving the consistency of cytology interpretation, reducing inter-observer variability. At the frontier, research into circulating tumor DNA (ctDNA) and microRNA signatures in blood promises to add a new layer of non-invasive surveillance. Together, these innovations are moving thyroid cancer diagnostics toward a future defined by accuracy, efficiency, and personalization.

The Growth in the Thyroid Cancer Diagnostics Market Is Driven by Several Factors…

The robust growth in the thyroid cancer diagnostics market is being fueled by a blend of technological, demographic, and healthcare policy-related factors. Rising global incidence of thyroid nodules-many requiring differentiation through advanced diagnostic techniques-is a key clinical driver. Increased use of high-resolution imaging technologies, such as ultrasound and CT scans, is uncovering a larger number of incidental thyroid nodules, many of which are being referred for diagnostic workup. The expanding availability of molecular diagnostics and genomic profiling in routine clinical practice is enabling more precise evaluation of indeterminate cases, thereby reducing diagnostic uncertainty and improving patient management pathways. Moreover, shifting clinical guidelines toward risk-based, personalized approaches to thyroid nodule evaluation are pushing hospitals and diagnostic labs to invest in integrated diagnostic platforms. Patient demand for non-invasive and accurate diagnostics is also influencing the adoption of liquid biopsy and advanced imaging tools. Aging populations, rising healthcare access in emerging economies, and growing awareness about endocrine cancers are further boosting diagnostic volumes. Additionally, the trend toward value-based care and outcome optimization is encouraging providers to adopt technologies that reduce unnecessary procedures and improve diagnostic accuracy, reinforcing the market momentum for advanced thyroid cancer diagnostics.

SCOPE OF STUDY:

The report analyzes the Thyroid Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Instruments, Consumables & Accessories); Test Type (Imaging Test, Biopsy, Blood Test, Other Test Types); End-Use (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bayer AG
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Canon Inc.
  • Cepheid
  • DiaSorin S.p.A.
  • Eli Lilly and Company
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Hologic Inc.
  • Illumina Inc.
  • Koninklijke Philips N.V.
  • Labcorp
  • Merck KGaA
  • Myriad Genetics Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Siemens Healthineers

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Thyroid Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Thyroid Cancer Drives Diagnostic Demand
    • Growing Preference for Non-Invasive Biopsy Techniques Spurs Market Growth
    • Advances in Molecular and Genetic Testing Strengthen Diagnostic Accuracy
    • Expansion of Personalized Treatment Protocols Throws Spotlight on Early Diagnosis
    • AI Integration in Radiology and Ultrasound Accelerates Screening Capabilities
    • Increased Awareness Campaigns Enhance Early Detection Rates
    • Rise in Female Patient Population Expands Addressable Market
    • Innovation in Fine Needle Aspiration Biopsy Tools Drives Market Acceptance
    • Demand for Companion Diagnostics with Targeted Therapies Enhances Adoption
    • Hospital and Diagnostic Lab Expansion in Emerging Markets Sustains Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Thyroid Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Thyroid Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Consumables & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cancer Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Associated Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Associated Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Associated Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Independent Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Independent Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Independent Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Imaging Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Imaging Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Imaging Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Blood Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • CHINA
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Thyroid Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • INDIA
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제